![Simon Sinclair](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Sinclair
Chief Tech/Sci/R&D Officer at
ONDINE BIOMEDICAL INC.
Net worth: 1 593 $ as of 2026-05-30
Profile
Simon Sinclair is currently Chairman at Reckitt Global Hygeine Institute, Director at Livingstone Global Ltd., Non-Executive Director at Renovos Biologics Ltd. since 2013, and Chief Medical Officer at Ondine Biomedical, Inc. since 2024.
Former roles include Director at DePuy International Ltd., Senior Director-Global Trial Optimization at Merck & Co., Inc. from 2008 to 2011, Director-International Clinical at Johnson & Johnson Medical Devices Cos.
from 2015 to 2018, Non-Executive Director at Coiled Therapeutics Plc from 2022 to 2026, Chief Safety Officer at Reckitt & Sons Ltd., and Chief Safety Officer at Reckitt Benckiser Group Plc from 2020 to 2023.
Education includes a doctorate from the University of Cambridge and an undergraduate degree from King's College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-06-26 | 10,843 ( 0% ) | 1 593 $ | 2026-05-30 |
Simon Sinclair active positions
| Companies | Position | Start |
|---|---|---|
| ONDINE BIOMEDICAL INC. | Chief Tech/Sci/R&D Officer | 2023-05-31 |
Renovos Biologics Ltd.
 Renovos Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in regenerative medicine technologies | Director/Board Member | 2013-02-28 |
Livingstone Global Ltd. | Director/Board Member | - |
Reckitt Global Hygeine Institute | Chairman | - |
Former positions of Simon Sinclair
| Companies | Position | End |
|---|---|---|
| ROQT THER | Director/Board Member | 2026-03-26 |
| RECKITT BENCKISER GROUP PLC | Corporate Officer/Principal | 2023-04-30 |
Johnson & Johnson Medical Devices Cos.
 Johnson & Johnson Medical Devices Cos. Medical SpecialtiesHealth Technology Manufactures medical devices | Corporate Officer/Principal | 2018-07-31 |
| MERCK & CO., INC. | Corporate Officer/Principal | 2011-01-31 |
DePuy International Ltd.
 DePuy International Ltd. Medical SpecialtiesHealth Technology Engages in manufacture of medical and dental instruments and supplies | Director/Board Member | - |
Training of Simon Sinclair
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Ondine Biomedical, Inc.
 Ondine Biomedical, Inc. BiotechnologyHealth Technology Engages in the development of non-antibiotic therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections | Health Technology |
Reckitt Benckiser Group Plc
 Reckitt Benckiser Group Plc Household/Personal CareConsumer Non-Durables Manufactures and markets household cleaning, health and nutrition products | Consumer Non-Durables |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reckitt & Sons Ltd.
 Reckitt & Sons Ltd. Financial ConglomeratesFinance Provides financial services | Finance |
DePuy International Ltd.
DePuy International Ltd. Medical SpecialtiesHealth Technology Engages in manufacture of medical and dental instruments and supplies | Health Technology |
Renovos Biologics Ltd.
Renovos Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in regenerative medicine technologies | Commercial Services |
Roquefort Therapeutics Plc
 Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
Johnson & Johnson Medical Devices Cos.
Johnson & Johnson Medical Devices Cos. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Livingstone Global Ltd. | |
Reckitt Global Hygeine Institute |
- Stock Market
- Insiders
- Simon Sinclair
